Nishan de Silva
2015
In 2015, Nishan de Silva earned a total compensation of $1.5M as Former VP, Finance and Strategy and Chief Financial Officer at Ligand Pharmaceuticals, a 47% decrease compared to previous year.
Compensation breakdown
| Option Awards | $672,584 |
|---|---|
| Salary | $137,903 |
| Stock Awards | $666,456 |
| Other | $5,050 |
| Total | $1,481,993 |
de Silva received $672.6K in option awards, accounting for 45% of the total pay in 2015.
de Silva also received $137.9K in salary, $666.5K in stock awards and $5.1K in other compensation.
Rankings
In 2015, Nishan de Silva's compensation ranked 6,053rd out of 13,638 executives tracked by ExecPay. In other words, de Silva earned more than 55.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,053 out of 13,638 | 56th |
Division Manufacturing | 2,265 out of 5,187 | 56th |
Major group Chemicals And Allied Products | 820 out of 1,857 | 56th |
Industry group Drugs | 656 out of 1,531 | 57th |
Industry Pharmaceutical Preparations | 511 out of 1,179 | 57th |
Source: SEC filing on April 12, 2016.
de Silva's colleagues
We found five more compensation records of executives who worked with Nishan de Silva at Ligand Pharmaceuticals in 2015.
2015
John Higgins
Ligand Pharmaceuticals
Chief Executive Officer
2015
Matthew Foehr
Ligand Pharmaceuticals
Chief Operating Officer
2015
Matthew Korenberg
Ligand Pharmaceuticals
Chief Financial Officer
2015
Charles Berkman
Ligand Pharmaceuticals
General Counsel
2015
Melanie Herman
Ligand Pharmaceuticals